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This paper describes symptoms and findings in a 57-year-old painter who had been exposed to
various organic solvents for over 30 years. He began to work as a paiter at 16 years of age, fre-
quently working in poorly ventilaed as; he used solvents to rem p fro the of his
arms and hands at the end of e wk sift The patient and hisf y ed short-
term memory function and change in afect in his early forties, whic until after he
stopped working and was thus no blonger exposed to paints and solvenut. Afie the. patient's expo-
sures had ended, serial neuropsychological testing revealed persisent cognitive deficits without
evidence of firther progression, and improvement in some domains. Magnetic resonance imag-
ing revealed global and symmetrical volume loss, involving more white thn gray matter. The
findings in this patient are consistent with chronic toxic encephalopathy and are differentiated
from other dementing processes such as Alzheimer's disease, multi-infarct (vascular) dementia,
and alcoholic dementia. Previous descriptions in the literature of persistent neurobehavioral
effects associated with chronic exposure to organic solvents corroborate the findings in this case.
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Case Presentation
A 57-year-old man was initially examined in
our clinic because of current memory diffi-
culties, disorientation, irritability, and insom-
nia. His wife recalled the appearance of subtle
changes in affect and memory problems as
much as 15 years before the patient was dis-
abled enough to seek medical attention
specifically for these problems. His condition
had progressively worsened since his wife first
noticed it, until he had to stop working.
Subsequent examinations showed that there
was no further progression of illness after the
exposure to various paints and solvents
ceased, but despite some improvement, many
features of his disability remain severe after
almost 4 years without further exposure.
Boston Occupational and
Environmental Neurology
Questionnaire
Work history. The patient began working as
a painter at 16 years of age. He worked for
the same company from age 16 to 21 years
(1954-1959); during this time he primarily
spray painted the exteriors of gasoline storage
tanks. When necessary, he also assisted the
metal alloy welders who made repairs to the
insides of the tanks and spot-primed and
painted the repaired metal. He did not use a
respirator; his only protection from the
paint fumes came from breathing through a
rag that he wrapped around his face.
At 21 years of age, he began painting the
interiors and exteriors of residential housing.
From 22 to 24 years of age (1959-1962), he
worked painting interiors of university
buildings with a variety of oil-based paints.
From 1962 to 1988, he painted the interiors
of commercial buildings (stores and office
buildings). He frequently painted the inside
of poorly ventilated walk-in type refrigera-
tors in grocery stores. To protect the
employees and customers of the stores from
becoming ill from the paint fumes, the job
foreman often closed the door, thus forcing
the patient and his co-workers to paint in an
unventilated area without respirators for up
to 2 hr. The patient and his co-workers
often experienced nausea, dizziness, and
staggering gait while painting in these con-
fined spaces. Although none of the painters
ever lost consciousness, their symptoms were
often severe enough to necessitate leaving the
refrigerator for relief.
Exposure history. For most of his career
the patient used oil-based paints. He was
forced to retire because of disability in 1995
at 57 years of age. Material safety data
sheets (MSDS) provided by this employer
indicated that the patient and his co-workers
had been exposed to lead, titanium dioxide,
creosote, and mixed solvents including
ammonia, chlorine bleach, various alcohols
(e.g., isopropanol and methanol), methyl
ethyl ketone, methyl isobutyl ketone,
formaldehyde, carbon tetrachloride, methyl-
ene chloride, ethylene glycol, propylene gly-
col, hexylene glycol, nitroethane, cyclohexa-
none, acetone, xylene, toluene, benzene, and
petroleum naphthas. The patient frequently
used painter's naphtha to clean off his
hands, arms, and face at the end of his work
shift; painter's naphtha (also known as VM
& P naphtha or benzine) is a petroleum
derivative containing a mixture of C5-C
hydrocarbons.
Past medical history ofpatient and
family. The patient was born on 25
December 1938 in South Carolina to two
apparently healthy parents. There was no
family history of dementia, psychiatric dis-
ease, or other neurological illnesses, and
neither the patient's sister or parents suf-
fered from any of these diseases.
Currently, the patient smokes 1-1.5
packs of cigarettes per day. Although he no
longer drinks alcohol, in the past he con-
sumed one to three drinks each evening for
20 years; he did not drink during work or
on weekends, and he stopped drinking 10
years before presenting with his current
complaints. His childhood medical history
included German measles and pneumonia at
3 weeks of age. He experienced a mild head
trauma at age 12; although he was dazed, he
did not lose consciousness. He had gastroin-
testinal symptoms at age 49 (10 years before
we examined him) that were diagnosed as a
duodenal ulcer.
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Six years before the onset of his current
and persistent neurobehavioral impairments
he experienced episodes of dizziness and
numbness of his right arm, often aggravated
by painting with a brush. A computed
tomography (CT) scan of his head was nor-
mal. He was referred to a cardiovascular
specialist who diagnosed an occlusion of the
right subclavian artery, resulting in a "sub-
clavian steal syndrome"; surgery for this was
not deemed necessary, as the blood flow to
his arm and hand remained adequate.
Present illness and current symptoms.
The patient continued painting for many
years, despite occasionally experiencing
episodes of dizziness and headaches, which
were ameliorated when he was not exposed
to paint fumes. At the high point of his
career (1982-1984), the patient was consid-
ered a very capable and reliable worker; he
was able to supervise others and schedule
and assign tasks. He also gave the crew
members directions about how to get to the
various work-sites where they were assigned
on a particular day. During this time he
also frequently mixed paints to create spe-
cific colors, a task at which he was consid-
ered to be quite skilled.
The patient began to notice changes in
his mood and personality (he became more
irritable), as well as problems with his memo-
ry (he began to have difficulty remembering
the names of new workers). These symptoms
progressed gradually over the next 15 years
while he continued to work. By 1993, the
patient began to experience severe anxiety
attacks and depression. Symptomatic
improvement was obtained from setraline
hydrochloride and clonazepam during the 3
years before he stopped painting. He was
forced to retire in 1995 at 57 years of age
because of his memory problems, which by
then were causing him to frequently forget
the names of recently hired co-workers, his
difficulty with mixing paints, and his difficul-
ty in finding job sites (he frequently got lost).
He was examined by a neurologist for the
first time in 1996. The patient reported that
he frequently would get lost while driving his
car and needed to write things down in order
to remember them. In addition, he reported
that his memory problcems were making him
irritable, defensive, and depressed. Currently,
the patient requires cues from his wife to aid
in his recall, he has difficulty dressing at times,
he often has spatial disorientation problems,
and he continues to need medication (fluoxe-
tine hydrochloride and lorazepam) for his
apparent frustration and reactive depression.
On examination, he was oriented to
person, time, and place. There was no
dysarthria and his conversational speech was
fluent. He could read the notes that he used
to recall specific items he wanted to talk
about. His recall for recent events was
labored, but significantly improved since he
was first seen in 1996. His memory for past
events was intact. He continues to have dif-
ficulty with visual memory, and he reports
that he still gets lost when driving to and
from unfamiliar places. He could not
remember the color of his toothbrush, even
after his wife had repeatedly reminded him.
His wife stated that his visual memory
impairment was manifested by his difficulty
with object assembly tasks; he could still
take things apart, but he could not remem-
ber how to put them back together. The
patient stated that he had begun riding a
bicycle for exercise and reported that he had
no trouble finding his way around his
neighborhood, but he could not remember
when he started this exercise program. His
mood and affect was improved. No overt
gait disturbance was noted, as would be
seen with a peripheral neuropathy or cere-
bellar dysfunction.
Time-Exposure-Symptom Line
A time-exposure-symptom line (Fig. 1) of the
patient's past and current medical and expo-
sure history was constructed from information
obtained from the Boston Occupational and
Environmental Neurology Questionnaire (1),
a careful review of his medical and employ-
ment records, and from an interview with the
patient and his wife.
Physical examination. A physical exami-
nation (10 January 1996) revealed a well-
developed and well-nourished man whose
physical condition matched his chronological
age. His resting blood pressure was 120/80
and his pulse was regular. Auscultation of the
carotid arteries revealed no bruits, nor were
there any bruits over his subclavicular area.
He was well oriented to person, place, and
time. His free speech was fluent and his oral
comprehension, repetition, and naming were
intact. He had difficulty with reciting serial
"7s" but he subtracted "3s" correctly. He was
able to spell the word "world" forward and
backward.
His extraoccular eye movements were
intact and there was no nystagmus. Pupils
were equal and reactive to light and there
was no evidence of papilledema. Facial sen-
sation was intact symmetrically, the gag
reflex was present, and there was no
dysarthria. Motor examination revealed nor-
mal bulk, tone, and strength in the upper
and lower extremities. Deep tendon reflexes
were present and normal (2+); plantar
reflexes were flexor. Sensory examination
including testing of touch, vibration, and
pain, and temperature sensation was nor-
mal. However, there was no hair on areas of
his lower legs that were normally covered by
socks. Performance on finger-to-nose, heel-
to-shin, and tandem gait were normal, and
he was able to hop without difficulry.
Biochemical diagnosis. Although he was
symptomatic when acutely seen, biological
markers including urine hippuric acid were
not obtained to document his exposure at
that time. A heavy-metal screen done
approximately 1 year after cessation of
exposure to paint and painting materials
revealed a blood lead level of 13 pg/dl and a
Figure 1. Time-exposure-symptom line (TES-linel demonstrating the chronological relationship between the patient's history of exposures to paints and sel'ents
and the progression of his neurobehavioral manifestations. Abbreviations: BPb, blood lead level; EEG, electroencephalogram; MRI, magnetic resonance imaging.
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mercury level of 5 pg/I, and manganese was
not detectable. A complete blood count and
thyroid tests were normal. Liver function
tests, induding serum glutamic-oxaloacetic
transaminase, serum glutamic pyruvic
transaminase, total bilirubin, alkaline phos-
phatase, albumin, and protein, were nor-
mal. Lyme titer was also negative.
Neurophysiological diagnosis. The elec-
troencephalogram (EEG) of this patient
done in 1996 was characterized by exces-
sive theta activity. Low to medium voltage
sharp activity was noted in the posterior
(occipital) area. A moderate amount of beta
(fast) activity was also seen superimposed
over the background activity. Response to
photic driving was normal, and no frank
epileptiform activity was seen. Nerve con-
duction studies were not performed on this
patient, who also had no clinical evidence
of peripheral neuropathy.
Neuroimaging. Magnetic resonance
imaging studies were made 6 months after
the patient first sought medical attention for
his cognitive deficits (1996). Symmetry and
the general cerebral architecture were intact
except for subtle findings related to a gener-
alized volume loss. The sulcal markings were
wider than expected for the patient's age.
This is best observed on the T2-weighted
axial images (Fig. 2A). The amount of vol-
ume loss observed at the base of the brain
was similar to that seen in the frontal and
parietal lobes. The temporal horns of the lat-
eral ventricles were well recognized, but did
not appear out of proportion to the remain-
der of the ventricles. White matter tracts
were symmetrical, but were qualitatively
thinned throughout. The signal within the
white matter was uniform and of normal
intensity. The cortical ribbon in the supra-
tentorial neocortex was uniform and normal
in signal throughout, but thinner than
expected for a patient of this age.
Tl-weighted coronal images revealed
that the medial temporal lobes were normal
in signal and configuration and were not
disproportionately atrophied (Fig. 2B). The
hippocampal formations were of normal
architecture and signal. Although the
archicortex of the entorhinal structures had
an apparently increased signal, a dispropor-
tionate change in volume was not noted.
The deep nuclei had normal position and
architecture. The head of the caudate was
not atrophied, but did show an increased
T2-weighted signal bilaterally. Similar sym-
metric findings were seen in the putamina.
The globi pallidum were of normal struc-
ture and signal intensity. The images of the
brainstem (mesencephalon, pons, and
medulla) were normal in signal strength
and size. On Ti-weighted midsagittal
images, the cerebellum appeared moderately
atrophied, but this was not disproportionate
to that seen in the cerebral cortex. (Fig. 2C)
The neuroimaging findings in this
patient can be summarized as indicative of
global and symmetric volume loss, involving
more white than gray matter. The abnormal
findings noted in the magnetic resonance
imaging (MRI) of this patient (Fig. 2) are in
stark contrast with the normal findings of
the CT scan performed 8 years earlier.
These findings can thus be chronologically
related to the clinical progression of this
patient's cognitive deficits that were unre-
markable 8 years earlier (in 1988), but
which had reached maximum severity by the
time the second neuroimaging study was
performed (in 1996).
Neuropsychological diagnosis. Neuropsy-
chological assessment (1996) revealed a full
scale IQ of 93 (Verbal IQ = 96; Performance
IQ= 91). Impaired performance was noted on
tests of verbal (California Verbal Learning
Test) and nonverbal memory (delayed repro-
duction of Rey-Osterreith complex figure).
Performance on tests of attention and execu-
tive function (Trails A and B and Wisconsin
Card Sort Test) was impaired as well.
Vlsuomotor coordination (Grooved Pegboard
Test) was also below expectation. Tests of
mood and affect revealed anxiety and depres-
sion. Tests of language function, including
confrontation naming (Boston Naming Test),
were within normal limits.
A second neuropsychological assessment
done 1 year later (in 1997) revealed a full
scale IQ of 90 (Verbal IQ = 92; Performance
IQ = 88). His performance was impaired on
tests of attention and executive function
(Trails A and B and Wisconsin Card Sort
Test). His scores on tests of visuospatial
planning and organization (copy of Rey-
Osterreith complex figure; Hooper Test of
Visual Organization) were below expecta-
tion. Deficits in visuomotor coordination
(Grooved Pegboard Test) were also noted.
Remote memory was intact, but his perfor-
mance on tests of verbal (California Verbal
Learning Test) and nonverbal memory
(delayed reproduction of Rey-Osterreith
complex figure) remained below expectation.
Language functions including spontaneous
speech and confrontation naming (Boston
Naming Test) were intact. The findings of
this follow-up assessment demonstrated a
persistent impairment of cognitive function
and supported the diagnosis of chronic toxic
encephalopathy. Such static deficits on serial
neuropsychological testing and the preserva-
tion of language function are not seen in
progressive dementing processes such as
Alzheimer's disease and multi-infarct demen-
tia, both ofwhich are associated with marked
worsening of performances on serial neu-
robehavioral assessments.
Discussion
Toxic effect oforganic solvents. Painters are
frequently exposed to mixtures of organic
solvents, including naphtha, toluene, xylene,
and n-hexane. Acute exposures to high con-
centrations of these solvents results in the
immediate onset of symptoms of inebria-
tion, dizziness, headache, nausea, and vom-
iting that can easily be related chonologically
Figure 2. Magnetic resonance imaging studies in a patient (a former painter) with chronic toxic encephalopathy (1.5-tesla magnet). (A) T2-weighted axial image
through the lateral ventricles demonstrating cortical atrophy. (B) Ti-weighted coronal image demonstrating diffuse cortical atrophy and that the temporal lobes
and hippocampi are not disproportionately atrophied. (C) Ti-weighted midsagittal image demonstrating proportional atrophy of the cerebellar vermis.
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to the exposure situation (2). Unless the
exposure concentrations were high enough
to be fatal, these symptoms are usually tran-
sient and therefore are ameliorated by
removal of the affected person(s) from expo-
sure. Conversely, symptoms associated with
chronic exposures appear gradually.
Workers are often unaware that nonspecific
symptoms, such as headache, irritability,
and insomnia, may indicate exposure to haz-
ardous chemicals and that they are at risk of
developing more persistent effects. Often,
overt symptoms including poor attention,
mood changes, memory problems, and
delirium, and even inebriation with associat-
ed ataxia and incoordination, may be
ignored by the affected person until they
interfere with daily tasks. The affected work-
er may not seek medical attention even
when these abnormal behaviors are pointed
out by co-workers or family members.
Similar neurological signs and symptoms
arise from the same principal neuroanatomi-
cal structures; thus, the symptoms of solvent
exposure may resemble those of primary neu-
rological diseases. A diagnosis of a neurotoxic
syndrome following chemical exposure must
be differentiated from a neurological disease
of non-neurotoxic etiology that is not associ-
ated with chemical exposure. Idiopathic
(nontoxic) neurologic disease usually follows
a progressive course, with continued develop-
ment of symptoms in the absence of any
identified exposure to neurotoxicants. The
exact chemical exposures experienced by this
patient who had been exposed to various oil-
based and latex paints, paint thinners, and
other solvent-containing materials, such as pit
glaze and glue, cannot be ascertained.
Determining the possible contribution of any
particular solvent to this patient's illness
requires consideration of the effect of the
enhancement of metabolism associated with
chronic exposure to a mixture of industrial
solvents and ethanol. In this case, the effects
of chronic exposure to the combinations of
solvents that the patient had reportedly been
exposed to was most likely "additive" because
few of these solvents would have enhanced
the toxicity of one another. One example is
the competitive inhibition of toluene metab-
olism due to exposure to other benzene deriv-
atives such as xylene. In such a case, the blood
levels of both parent molecules would have
been increased. However, the patient's chron-
ic exposure to ethanol and other organic sol-
vents that induce cytochrome P450 enzymat-
ic activity would have had synergistic effects
on the toxicity of carbon tetrachloride, which
is metabolized to the trichloromethyl free
radical (C13C*) (3,4). The contribution of
free radicals to oxidative stress and cell mem-
brane dysfunction is a well-recognized mech-
anism of neurotoxicity (5).
The possibility that this patient's current
cognitive deficits are due to his exposure to
toluene and other benzene derivatives, as
well as the numerous aliphatic hydrocarbons
to which he was exposed, is consistent with
other published reports of the neurotoxic
effects of these solvents. Acute effects of
exposure to toluene include dimmed vision,
headache, fatigue, confusion, lightheaded-
ness, inebriation, attention and memory
deficits, disturbed equilibrium and coordina-
tion, and occasionally nausea, vomiting, or
unconsciousness (6). Unrecognized acute
effects of toluene exposure may be mistaken
for mood and affective disorders, such as
manic-depressive illness or schizophrenia (7).
Chronic toxic encephalopathy follows
long-term exposure to toluene and is char-
acterized by apathy, inattention, poor mem-
ory, and impaired performance of complex
cognitive function. Mood swings, irritabili-
ty, and anxiety attacks occur early, followed
by memory impairments and problem-solv-
ing difficulties. The absence of anomia is a
principal finding that differentiates a
dementia due to toluene exposure from the
progressive dementias such as vascular dis-
ease or Alzheimer's disease (8-10). Chronic
exposure to toluene has been associated
with significant central nervous system
effects resulting in cerebral and cerebellar
atrophy. Toluene-induced chronic toxic
encephalopathy is associated with white
matter changes (11); thus, in some cases, it
may be difficult to distinguish it from
multi-infarct vascular disease with related
dementia. Because increasing duration of
exposure is correlated with increasing age of
the exposed workers, the effects of aging are
a potential confounder in the diagnosis of
chronic toxic encephalopathy. However,
the symptoms associated with exposure to
toluene and other industrial solvents typi-
cally stabilize or improve after cessation of
exposure; although progression may be seen
in some older individuals, such a progres-
sion is typically not as rapid as that seen in
idiopathic progressive dementing processes
such as Alzheimer's disease (10).
Exposure to mixed organic solvents,
induding aliphatic hydrocarbons and benzene
derivatives, has been associated with central
and peripheral nervous system dysfunction
(1,12-14). Organic solvents are lipophilic
and are readily absorbed via pulmonary, gas-
trointestinal, and dermal routes; then they
readily cross the blood-brain barrier. Many
organic solvents are also metabolized to alco-
hols (e.g., hexanol and trichloroethanol). The
alcohol metabolites of organic solvents are
responsible for many of the acute narcotic
effects associated with exposures to these
chemicals. Further metabolism of the alcohol
metabolites of organic solvents leads to the
formation of aldehydes that can also react
with cellular macromolecules, thereby dis-
rupting cellular processes. Because these
metabolites share common mechanisms of
action, concurrent exposures to several organ-
ic solvents can have additive, synergistic,
and/or potentiating effects on nervous system
functioning.
Once absorbed, organic solvents are
metabolized by enzymes such as cytochrome
P450. These enzymes are located primarily
in the liver but are also found, to a lesser
extent, in other tissues including the brain.
Simultaneous acute exposure to high concen-
trations of mixed organic solvents results in
competition for drug-metabolizing enzymes
and thus higher blood levels of the parent
molecule. Conversely, chronic exposure to
organic solvents, such as ethanol or com-
monly used pharmaceutical drugs such as
phenobarbital, induces the activity of drug-
metabolizing enzymes induding cytochrome
P450, which results in enhanced formation
and excretion of metabolites (4,15). Solvents
can be metabolically deactivated or activated
by the cytochrome P450 monooxygenase
system. Because not all metabolites are less
toxic than the parent molecule, induction of
drug-metabolizing enzymes can enhance the
in vivo toxicity of an organic solvent or phar-
maceutical drug. Metabolic activation by
cytochrome P450 results in the formation of
electrophilic alkylating agents (i.e., molecules
containing an electron-deficient atom with a
positive charge that can covalently bind with
the nucleophilic centers of cellular macro-
molecules to form adducts) (16,14).
Definition oftoxic encephalopathy. The
neurobehavioral effects of exposure to neu-
rotoxicants can be classified according to
the clinical manifestations, temporal profile
of the symptoms, and the nature of recov-
ery or residual deficits (18). There are four
categories of toxic encephalopathies:
* Acute organic mental disorder: mild,
transient, and reversible symptoms of
acute intoxication [for example, a brief
exposure to volatile and aromatic sub-
stances, such as glue or varnish in a poor-
ly ventilated area or ingestion of com-
mon ethyl alcohol (ethanol), produces an
acute organic mental disorder]
* Acute toxic encephalopathy: associated
with permanent residual cognitive
impairment, which often occurs after an
overwhelming acute exposure that in the
worst cases can result in coma or death
* Organic affective (mood) syndrome:
can develop insidiously with subacute
or chronic exposures and can last from
weeks to years. The symptoms of this
syndrome are sometimes incorrectly
attributed to primarily psychiatric dis-
orders because they consist of mood
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disturbances and affect changes includ-
ing depression, irritability, fatigue, and
anxiety. Consideration of other concur-
rent findings on neurological examina-
tion along with the results of formal
neuropsychological testing allows the
clinician to reconcile discrepancies and
to corroborate the test results
Chronic toxic encephalopathy: describes
patients who present with affective distur-
bances as well as cognitive deficits. The
cognitive and affective disturbances seen
in these patients interfere with perfor-
mance of activities of independent daily
living and gaining meaningful employ-
ment is often impossible. The neuropsy-
chological test findings in chronic toxic
encephalopathy are for the most part per-
manent, although some improvement
may be seen in some cognitive domains
following removal of the patient from the
source of exposure (18).
Elofsson et al. (13) reported a similar
neuropsychological profile with marked
memory and manual dexterity performance
deficits and intact verbal performance
among a group of 80 car painters, whose test
scores were compared with those of 80
unexposed controls. An epidemiologic
investigation of 3,303 Danish males 57-75
years of age (mean of 62.5 years) revealed an
increased incidence of attention, memory,
and psychiatric problems among workers
who had been exposed to solvents for peri-
ods >5 years (1S). The EEG findings seen in
the patient presented here are consistent
with findings reported in other workers
exposed to mixed solvents. The EEG studies
in 87 workers diagnosed with chronic toxic
encephalopathy showed diffuse slow wave
abnormalities but no epileptiform activity
(20). The MRI findings in this patient are
consistent with the neuroimaging (CT
scans) reported by Arlien-S0borg et al. (12),
who revealed diffuse cerebral atrophy in a
group of house painters.
Differential diagnosis. The history and
neuropsychological findings in the patient
presented here are consistent with the insid-
ious onset of an organic affective syndrome
that gradually evolved, with his continued
exposure to organic solvents, into a chronic
toxic encephalopathy. The neuropsycholog-
ical findings in this patient are atypical for
the dementia of Alzheimer's disease, given
the absence of naming problems (anomia)
and the lack of progression of the dementia.
The possibility that these findings may be
due to other dementing processes such as
cerebrovascular disease (e.g., multi-infarct
dementia) was also ruled out because of the
stability of his performance over time.
The possibility of ethanol contributing
to this patient's current symptoms cannot be
disregarded. Chronic intake of ethanol has
been associated with neuroimaging and
EEG abnormalities (21-23). However, the
aforementioned findings are consistently
associated with consumption of at least 60 g
ethanol/day; this patient usually consumed
only two to three drinks (approximately
24-36 g) per day. The amount of chronic
ethanol intake seen in this patient is consis-
tent with the definition of a moderate social
drinker, and consumption of fewer than five
alcoholic drinks per day would not put an
adult male at an increased risk for cognitive
deficits (24). Furthermore, removal from
organic solvents, including ethanol, is typi-
cally associated with improvement or stabi-
lization in cognitive functioning (22,25),
whereas he cognitive symptoms reported by
this patient had actually progressed since he
stopped drinking. In contrast, his symptoms
have improved since he retired and thus
ended his exposure to industrial organic sol-
vents; this further supports the diagnosis of
chronic toxic encephalopathy due to his
exposure to organic solvents. Furthermore,
this patient does not show any marked con-
current clinical evidence of the peripheral
neuropathy or cerebellar ataxia that would
be expected with heavy alcohol intake. The
absence of peripheral neuropathy also sug-
gests that this patient's cognitive symptoms
are not due to malnutrition or diabetes,
both of which are associated with peripheral
neuropathy; the diagnoses of malnutrition
and/or diabetes were also not supported by
serial laboratory studies (26,27).
Diseases that may lead to similar MRI
findings as in this case include cerebrovascular
and neurodegenerative disorders and the
chronic sequelae of anoxia, trauma, infection,
and metabolic or toxic encephalopathy. A sig-
nificant observation that is useful in making a
differential diagnosis is the lack of a T2-
weighted signal change, which is representa-
tive of demyelination or reactive gliosis.
Chronic cerebrovascular disease is commonly
associated with increased signal in the periven-
tricular white matter. Often this pattern fol-
lows the general distribution of the deep bor-
der zone territory. This is seen in the "chronic
small vessel diseases," particularly microan-
giopathy of hypertension, lipohyalinosis, and
amyloid angiopathy. These periventricular
changes are often confluent, but may have
focal, patchy areas of signal abnormality repre-
sentative of small regional infarct. Without
these white matter changes, it is difficult to
diagnose cerebrovascular disease.
In the earliest stages, the neurodegenera-
tive disorders may be difficult to recognize.
As these diseases progress, however, charac-
teristic changes become apparent. Noting the
lobar distribution, such as the temporopari-
etal predominance in Alzheimer's disease,
may be helpful in the diagnosis. A fron-
totemporal distribution, with sparing of the
posterior aspect of the superior temporal
gyrus (striate cortex), is commonly seen in
Pick's disease. A medial temporal (rhin-
encephalon) wasting is also relatively com-
mon in these disorders. Loss of deep nuclear
structures such as selective early loss of cau-
date mass or signal abnormality in the stria-
tum are reflective of such diseases as
Huntington's chorea or Creutzfeldt-Jakob
disease, respectively. Some neurodegenerative
diseases have either a lack of or very subtle
findings. Diseases in the spectrum of multi-
systems atrophy and chronic Wernicke's
encephalopathy, for example, can be quite
difficult to detect. Volume loss specific to the
midbrain is commonly described in multisys-
tems atrophy, but in practice, these changes
occur quite late in the disease and are often
difficult to recognize because standard imag-
ing measurements are not available for the
midbrain (28). The T2 dark changes of
chronic microhemorrhage in shrunken
mammillary bodies, hypothalamus, and den-
tate nuclei are often overlooked in chronic
Wernicke's encephalopathy.
The differential diagnosis of chronic
toxic encephalopathy depends on the exclu-
sion of other possible etiologies, including
the neurodegenerative diseases, and the
chronological association of the exposure
situation with the onset and progression of
the clinical, neurophysiological, neuropsy-
chological, and neuroimaging findings in
the patient. In this case the neuroimaging
findings and neuropsychological test results
could be related chronologically to the
exposure events and to the progression of
the patient's illness. In addition, the neu-
roimaging and neuropsychological findings
do not support an alternative diagnosis.
The patient's chronic consumption of
alcohol during most of his professional career
would have induced enzymatic activity (e.g.,
cytochrome P450). Although this would have
enhanced the neurotoxic potential of some of
the solvents to which he was exposed, induc-
tion of drug metabolizing enzymes could also
have had a protective effect by enhancing
conjugation and thus excretion of the
metabolites of these chemicals. Many of the
solvents to which this patient was exposed
(e.g., methyl ethyl ketone, methyl isobutyl
ketone, formaldehyde, propylene glycol, chlo-
rine bleach, toluene, benzene, and petroleum
naphthas) are not metabolically activated.
Therefore, this patient's chronic consump-
tion of ethanol throughout much of his
working life would most likely have protected
him from the effects associated with increased
blood levels of those solvents, such as
formaldehyde, that do not require metabolic
activation to induce their toxic effects.
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Nevertheless, the toxicity ofsome of the other
solvents to which he was exposed, including
methylene chloride, would have been
enhanced by induction of cytochrome P450
activity. Methylene chloride is primarily
metabolized to carbon monoxide (CO) in the
liver. Increased blood levels ofCO are associ-
ated with tissue hypoxia. In this case, the
patient's habit ofsmoking up to one and one-
half packs of cigarettes per day also con-
tributed to his total exposure to CO.
Therefore, although the contribution ofCO-
induced tissue hypoxia to this patient's neu-
rologic illness should be considered, it was
most likely minimal. If CO were an impor-
tant factor, we would expect his MRI to show
abnormalities in the globus pallidus and
demyelination in the centrum semiovale. In
addition, the clinical neurologic picture
would be expected to include features of
parkinsonism (1).
Conclusion and Prognosis
The findings in this patient are consistent
with chronic toxic encephalopathy due to
solvent exposure and are atypical for
Alzheimer's disease, given preservation of
language skills, the absence ofnaming prob-
lems (anomia), and the lack of progression
of the dementia. Based on the MRI studies
and the stability of his performance over
time, it it unlikely that these findings were
due to other dementing processes such as
cerebrovascular disease (e.g., multi-infarct
dementia). The diffuse MRI findings and
neuropsychological test results in this
patient are consistent with reported cases of
chronic toxic encephalopathy in house
painters. The EEG findings for this patient
are consistent with findings for other work-
ers exposed to mixed solvents.
The prognosis for full recovery in this
patient is poor. At follow-up examination
(25 September 1998), the patient reported
that he had stopped attending psychological
rehabilitation therapy sessions because he
was "frustrated and was getting nowhere";
he also felt that the sessions were "not doing
him any good." He is permanently disabled.
His anxiety and depression may have been
exacerbating his symptoms somewhat; thus,
continued symptomatic anxiolytic and anti-
depressant therapy is necessary. Ongoing
abstinence from alcohol and a significant
reduction in caffeine intake was strongly
encouraged. Assistance with the develop-
ment of mnemonic strategies such as a
structured memory logbook has been pro-
vided, but this patient's cognitive impair-
ments, particularly his memory problems,
do not allow him to learn or gain insight
from such intellectual input.
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